Paxlovid too toxic for mild diesease

SAPHRA, has authorised Paxlovid for mild Covid, which, if mild is self limiting, needing hardly any pharmacological intervention.
This decision is utterly reckless and these scientists must be questioned for their decision.
Paxlovid has over 115 drug interactions, which could be fatal.